Chemoinformaics analysis of (+)-GALLOCATECHOL
| Molecular Weight | 306.27 | nRot | 1 |
| Heavy Atom Molecular Weight | 292.158 | nRig | 17 |
| Exact Molecular Weight | 306.074 | nRing | 3 |
| Solubility: LogS | -2.88 | nHRing | 1 |
| Solubility: LogP | 0.736 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 39.9991 |
| nHD | 6 | BPOL | 15.7809 |
| QED | 0.437 |
| Synth | 3.521 |
| Natural Product Likeliness | 2.272 |
| NR-PPAR-gamma | 0.921 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.003 |
| HIA | 0.274 |
| CACO-2 | -6.306 |
| MDCK | 0.00000389 |
| BBB | 0.019 |
| PPB | 0.911575 |
| VDSS | 0.572 |
| FU | 0.0979995 |
| CYP1A2-inh | 0.095 |
| CYP1A2-sub | 0.124 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.174 |
| CYP2c9-sub | 0.52 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.224 |
| CYP3a4-inh | 0.142 |
| CYP3a4-sub | 0.15 |
| CL | 17.081 |
| T12 | 0.87 |
| hERG | 0.067 |
| Ames | 0.437 |
| ROA | 0.187 |
| SkinSen | 0.958 |
| Carcinogencity | 0.036 |
| EI | 0.902 |
| Respiratory | 0.085 |
| NR-Aromatase | 0.623 |
| Antiviral | Yes |
| Prediction | 0.836236 |